High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer’s Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection-Reference-Cited by-同舟云学术

High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer’s Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection

Published:2014-06-16 Issue:8 Volume:5 Page:718-730
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Fawaz Maria V.¹,Brooks Allen F.¹,Rodnick Melissa E.¹,Carpenter Garrett M.¹,Shao Xia¹,Desmond Timothy J.¹,Sherman Phillip¹,Quesada Carole A.¹,Hockley Brian G.¹,Kilbourn Michael R.¹,Albin Roger L.²³,Frey Kirk A.¹,Scott Peter J. H.¹

Affiliation:

1. Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States

2. Geriatrics Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan 48105, United States

3. Department of Neurology, The University of Michigan Medical School, Ann Arbor, Michigan 48109, United States

Funder

National Institutes of Health

Alzheimer's Association

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link